Full Member
Mayssa Abdel Hady
Membership since:
2025
Field of activity:
Other Memberships/Affiliations
Society for women in science in Developing Countries (OWSD National Chapter) –Egypt
Degrees:
2016
Doctorate Medical and Health Sciences incl Neurosciences
Publications resulting from Research
1.Tellurim/Vanadate dopted hydroxyapatite nano-scaffold carrier for doxorubicin colon cancer targeting. Mayssa Abdel Hady, M.K.Ahmed, Egyptian Journal of Chemistry, accepted (2023)
2. Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; A different prospective. Mayssa Abdel Hady, AB Darwish, MS Abdel-Aziz, OM Sayed, Colloids and Surfaces B: Biointerfaces, 211, 112304 (2022).
3. Nanofibrous ε-polycaprolactone scaffolds containing Ag-doped magnetite nanoparticles: Physicochemical characterization and biological testing for wound dressing applications in vitro and in vivo. M.K.Ahmed, M.A.Zayed, S.I.El-dek, Mayssa AbdelHady, Doaa H.El Sherbiny, VukUskoković, Bioactive Materials, 6 (7), 2070-2088 (2021).
4. Polycaprolactone based electrospun matrices loaded with Ag/hydroxyapatite as wound dressings: Morphology, cell adhesion, and antibacterial activity. Abeer A Hassan, Hyam A Radwan, Said A Abdelaal, Najlaa S Al-Radadi, MK Ahmed, Kamel R Shoueir, Mayssa Abdel Hady, International Journal of Pharmaceutics, 593: 120143 (2020).
5. Buccal mucosal accumulation of dapoxetine using supersaturation, co-solvent and permeation enhancing polymer strategy.MA Akl, MA Hady, OM Sayed, Journal of Drug Delivery Science and Technology, 55: 101411(2020).
6. Highly ordered functionalized mesoporous silicate nanoparticles reinforced poly (lactic acid) gatekeeper surface for infection treatment. Mostafa F Abdelbar, Raef S Shams, Ossama M Morsy, Mayssa Abdel Hady, Kamel Shoueir, Rehab Abdelmonem, International Journal of Biological Macromolecules,156 , 858-868(2020).
7. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Mayssa Abdel Hady, Ossama M Sayed, Mohamed A Akl, Colloids and Surfaces B: Biointerfaces, 193, 111076 (2020).
8. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma. HA Salama, M Ghorab, AA Mahmoud, Mayssa Abdel Hady, AAPS PharmSciTech,1-12 (2017).
9. Brinzolamide Loaded-Polymeric Nanoparticles. HA Salama, M Ghorab, AA Mahmoud, Mayssa Abdel Hady, Current Science Internationa., 5(2): 147-151(2016).
10. Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Salama, H. A., Mahmoud, A. A.,Kamel, A. O., Abdel Hady, M., Awad, G. A. S., Colloids and Surfaces B: Biointerfaces, 100:146-54 (2012).
11. Brain delivery of olanzapine via intranasal administration of transfersomal vesicles. Salama, H. A., Mahmoud, A. A.,Kamel, A. O., Abdel Hady, M., Awad, G. A. S., J. Liposome Res., 22(4):336-45 (2012)
2. Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; A different prospective. Mayssa Abdel Hady, AB Darwish, MS Abdel-Aziz, OM Sayed, Colloids and Surfaces B: Biointerfaces, 211, 112304 (2022).
3. Nanofibrous ε-polycaprolactone scaffolds containing Ag-doped magnetite nanoparticles: Physicochemical characterization and biological testing for wound dressing applications in vitro and in vivo. M.K.Ahmed, M.A.Zayed, S.I.El-dek, Mayssa AbdelHady, Doaa H.El Sherbiny, VukUskoković, Bioactive Materials, 6 (7), 2070-2088 (2021).
4. Polycaprolactone based electrospun matrices loaded with Ag/hydroxyapatite as wound dressings: Morphology, cell adhesion, and antibacterial activity. Abeer A Hassan, Hyam A Radwan, Said A Abdelaal, Najlaa S Al-Radadi, MK Ahmed, Kamel R Shoueir, Mayssa Abdel Hady, International Journal of Pharmaceutics, 593: 120143 (2020).
5. Buccal mucosal accumulation of dapoxetine using supersaturation, co-solvent and permeation enhancing polymer strategy.MA Akl, MA Hady, OM Sayed, Journal of Drug Delivery Science and Technology, 55: 101411(2020).
6. Highly ordered functionalized mesoporous silicate nanoparticles reinforced poly (lactic acid) gatekeeper surface for infection treatment. Mostafa F Abdelbar, Raef S Shams, Ossama M Morsy, Mayssa Abdel Hady, Kamel Shoueir, Rehab Abdelmonem, International Journal of Biological Macromolecules,156 , 858-868(2020).
7. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Mayssa Abdel Hady, Ossama M Sayed, Mohamed A Akl, Colloids and Surfaces B: Biointerfaces, 193, 111076 (2020).
8. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma. HA Salama, M Ghorab, AA Mahmoud, Mayssa Abdel Hady, AAPS PharmSciTech,1-12 (2017).
9. Brinzolamide Loaded-Polymeric Nanoparticles. HA Salama, M Ghorab, AA Mahmoud, Mayssa Abdel Hady, Current Science Internationa., 5(2): 147-151(2016).
10. Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Salama, H. A., Mahmoud, A. A.,Kamel, A. O., Abdel Hady, M., Awad, G. A. S., Colloids and Surfaces B: Biointerfaces, 100:146-54 (2012).
11. Brain delivery of olanzapine via intranasal administration of transfersomal vesicles. Salama, H. A., Mahmoud, A. A.,Kamel, A. O., Abdel Hady, M., Awad, G. A. S., J. Liposome Res., 22(4):336-45 (2012)
UKICRS Symposium
2025
Aston University, Birmingham, UKat the 5th International Scientific Conference of Faculty of Pharmacy, Cairo University, Pharmacy at the cutting-edge: Facing Future Challenges
2025
Faculty of Pharmacy, Cairo Universitytraining course
2025
national research centre, cairo, egypttraining course
2025
national research centre, cairo, egyptParticipation in the 7th Annual International Conference of AIPC 2023,(organizing committee)
2025
CairoParticipation in the 5th Annual International Conference of AIPC 2021,(organizing committee)
2025
CairoParticipation in the 4th Annual International Conference of AIPC 2020,(organizing committee)
2025
CairoParticipation in the 3th Annual International Conference of AIPC 2019,(organizing committee)
2025
CairoParticipation in the 2nd Annual International Conference of AIPC 2018, Cairo, Egypt (organizing committee).
2025
CairoAttendance at the 6th International Conference of Pharmaceutical and Drug Industries Research Division entitled “ Research and Development in Drug Industry in Line with the Sustainable Development Goals of Egypt Vision 2030”.
2025
GizaAttendance in the 1st SCU Conference on Clinical Pharmacy entitled “Clinical Pharmacy between Reality and Expectations”
2025
Faculty of Pharmacy –Suez Canal University